Jackson Financial (JXN) Could Be 13% Undervalued As Legal Probe Tests Sentiment

Jackson Financial stock: why a legal probe suddenly matters

Pomerantz LLP’s investigation into Jackson Financial (JXN), launched after a short report from QVT Financial LP alleging opaque hedge loss treatment and inflated solvency metrics, has quickly turned into a key focus for shareholders.

Jackson Financial’s share price has pulled back in the short term, with the 1-day, 7-day and 30-day share price returns all in negative territory. However, the 90-day share price return of 11.09% and 1-year total shareholder return of 41.05% indicate that momentum has been building over a longer window as the latest legal probe tests how much risk investors are now willing to price in.

Compare Jackson Financial’s legal overhang and recent move with a curated group of resilient financials, screened for balance-sheet strength using our list of solid balance sheet and fundamentals (25 results).

Short term weakness on legal headlines and a strong multi year run put Jackson Financial in an awkward spot. Should investors accept current pricing based on that track record, or wait for a cleaner entry as the valuation case unfolds next?

Most Popular Narrative: 13% Undervalued

Jackson Financial last closed at $129.71 while the most followed narrative anchors fair value at $148.50, so the legal scrutiny now sits against a backdrop of a stock priced at a double digit discount to that framework.

The main thing that has to go right is that Jackson continues to turn strong statutory capital generation, its contingent capital facility and large liquidity buffers into reliable cash flows, without the emerging hedging and captive reinsurance scrutiny undermining confidence in Brooke Re or Jackson National Life.

Today's valuation implies the share price reflects significant concern about variable annuity risk and the short seller allegations around Brooke Re, even though the company is still reporting high RBC ratios, ongoing free capital generation and sizeable capital returns to shareholders.

See why 21 investors see Jackson Financial as 13% undervalued.

Result: Fair Value of $148.50 (UNDERVALUED)

Still, the narrative around Jackson Financial can change quickly if the hedging and Brooke Re allegations weaken confidence in capital strength or if private credit exposure drags on returns and free capital generation.

Find out about the key risks to this Jackson Financial narrative.

Another View: Jackson Financial on simple P/E math

The first narrative leans on Jackson Financial’s long term earnings potential and a fair value of $148.50. A plain P/E snapshot tells a very different story. The current P/E sits around 148.9x, while the US Diversified Financial industry averages 17.1x and peers sit near 24.3x.

The fair ratio for Jackson Financial is 20.2x, so today’s multiple is several times higher than where the market could eventually settle. That gap increases valuation risk if earnings or sentiment fall short of expectations. As an investor, is this a premium you feel comfortable paying while the legal probe unfolds?

See what the numbers say about this price — find out in our valuation breakdown.

Next Steps

Mixed views like these only matter if you compare them with your own assessment of Jackson Financial and then act decisively once you are comfortable. Start by weighing the 2 key rewards and 2 important warning signs.

Looking for more investment ideas beyond Jackson Financial?

Do not stop with Jackson Financial. Fresh opportunities elsewhere could balance your risk, sharpen your watchlist, and help you act faster when the next setup appears.

• Target quality at a discount by scanning companies with strong fundamentals using our 28 high quality undervalued stocks.
• Build a steadier income stream by hunting for reliable high yield payers through the 8 dividend fortresses.
• Limit downside risk by focusing on companies with robust finances via our curated 31 resilient stocks with low risk scores.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com